ClinicalTrials.Veeva

Menu

Effects of Green Propolis Extract (EPP-AF) on Inflammation in Hemodialysis Patients.

U

University of Sao Paulo General Hospital

Status and phase

Completed
Phase 2
Phase 1

Conditions

Chronic Kidney Disease Requiring Chronic Dialysis

Treatments

Drug: Propolis Period (Green Propolis 250mg/day)
Other: Control Period

Study type

Interventional

Funder types

Other

Identifiers

NCT04072341
Hospital São Rafael S.A

Details and patient eligibility

About

End-stage chronic kidney disease is associated with the condition of chronic inflammation. Patients on hemodialysis are known to be predisposed to several factors that predispose to inflammation: dialysis membranes, central venous catheters, oxidative stress, fluid overload, sodium overload, uraemic toxins. Propolis, a natural resin produced by bees from plant materials, has anti-inflammatory, immunomodulatory, and anti-oxidant properties. The aim of this study was to evaluate the impact of Brazilian green propolis extract on inflammation in hemodialysis patients.

Full description

Randomized open-label cross-over trial to investigate impact of Brazilian green propolis extract on inflammation in hemodialysis patients.

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age over 18 years;
  • Male or female on hemodialysis for at least 1 month.

Exclusion criteria

  • Pregnant Woman;
  • Carriers of active neoplasms;
  • Patients undergoing kidney transplantation during the study;
  • Infection during the study;
  • Patients who underwent parathyroidectomy during the study;
  • Patient using immunosuppressive drugs;
  • Allergy to propolis or any of its components;

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Propolis Period
Experimental group
Description:
Hemodialysis patients will be under regular treatment of their comorbidities and using Propolis.
Treatment:
Drug: Propolis Period (Green Propolis 250mg/day)
Control Period
Experimental group
Description:
Hemodialysis patients will be under regular treatment of their comorbidities, but without using Propolis.
Treatment:
Other: Control Period

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems